Skip to main content
Home
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
      • Specialties
        • Vaccines & Infectious Diseases
        • Ophthalmology
        • Clinical Neuroscience
        • Rare Disease
        • Cell & Gene Therapy
        • Government
      • Additional Specialties
        • Hematology
        • Oncology
        • Maternal & Child Health
        • Medical Devices
      • Clinical Services
        • Biostatistics
        • Clinical Data Management
        • Clinical Research Services
        • Clinical Trial Management
        • Global Regulatory Affairs
        • Pharmacovigilance & Medical Monitoring
    • Veridix - Tech & AI
      • eClinical Platform
        • EDC
        • Decentralized Clinical Trials
        • Health Navigator
        • RTSM
        • eCOA / ePRO
      • AI Agents
        • Biostats and Analysis Agent
        • Data Management Agent
        • Document Authoring
      • GlobalTrace
      • Analytics & Reporting
        • Clinical Pipelines
        • VERA
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us

Breadcrumb

  1. Emmes Group

Excess graft losses in adolescent recipients of living donor (LD) renal transplants (TX): A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS),

Go back to Resources

Excess graft losses in adolescent recipients of living donor (LD) renal transplants (TX): A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS),

Authors:

Location:

Go back to Resources

Evaluation of pre- and post transplant DST/CsA in non-HLA identical living donor kidney transplant recipients.

Go back to Resources

Evaluation of pre- and post transplant DST/CsA in non-HLA identical living donor kidney transplant recipients.

Authors:

Location:

Go back to Resources

Sensitivity with specificity of a screening questionnaire for dry eye,

Go back to Resources

Sensitivity with specificity of a screening questionnaire for dry eye,

Authors:

Go back to Resources

Sample-path insensitivity of symmetric queues in discrete-time.

Go back to Resources

Sample-path insensitivity of symmetric queues in discrete-time.

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Safety profile of Phase I and II preventive HIV tTpe 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation Group,

Go back to Resources

Safety profile of Phase I and II preventive HIV tTpe 1 envelope vaccination: experience of the NIAID AIDS Vaccine Evaluation Group,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Safety of kidney biopsy in pediatric transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS),

Go back to Resources

Safety of kidney biopsy in pediatric transplantation: A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS),

Authors:

Location:

Go back to Resources

Safety and immunogenicity of env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59,

Go back to Resources

Safety and immunogenicity of env 2-3, a human immunodeficiency virus type 1 candidate vaccine, in combination with a novel adjuvant, MTP-PE/MF59,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120,

Go back to Resources

Safety and immunogenicity of a candidate HIV-1 vaccine in healthy adults: recombinant glycoprotein (rgp) 120,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Risk factors for vascular thrombosis in pediatric renal transplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study,

Go back to Resources

Risk factors for vascular thrombosis in pediatric renal transplantation: a special report of the North American Pediatric Renal Transplant Cooperative Study,

Authors:

Secondary:

Volume:

Pagination:

Go back to Resources

Risk factors for vascular thrombosis (VT) in pediatric renal transplantation,

Go back to Resources

Risk factors for vascular thrombosis (VT) in pediatric renal transplantation,

Authors:

Location:

Go back to Resources

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 106
  • Page 107
  • Page 108
  • Page 109
  • Current page 110
  • Page 111
  • Page 112
  • Page 113
  • Page 114
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to
Emmes Group

Delivering Global Health
Impact Through People,
Science and Technology

Main navigation
  • Company
    • History
    • Leadership
    • Clients and Collaborators
    • By the Numbers
  • Capabilities
    • Emmes - CRO
    • Veridix - Tech & AI
  • Resources
    • Newsroom
    • Blog
  • Careers
  • Contact
    • Locations
    • Contact Us
linkedin X

Copyright ©, The Emmes Company, LLC

Footer
  • Cookie Policy
  • External Privacy Notice
  • FCOI
  • Emmes EU-U.S. Data Privacy Framework
  • Purchasing Terms and Conditions

Cookie Policy

Our site uses cookies for analytics and to improve our site and services. You can manage these cookies via your browser settings at any time. By continuing to use our site, you agree to our use of cookies. For more information, including how to change your settings, see our Cookie Policy.